Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability and food effect of a new VX-993 tablet formulation; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• VX-993

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Pain | Phase 1 | Status: COMPLETED